Fig. 2.
Fig. 2. Prelymphoid origin of G8600A mutation in B-CLL 33. / (A) G8600A mutation in DNA from tumor cells of patient with B-CLL 33 (i), separated to 99.8% purity using CD19 PE-coated magnetic beads (ii). (B) G8600A mutation together with a small peak of a normal sequence in DNA from CD3+ cells of patient with B-CLL 33 (i), separated to 95% purity using CD3 PE-coated magnetic beads (ii). (C) G8600A mutation in DNA from CD14+ cells of patient with B-CLL 33 (i) separated to 100% purity using CD14 labeling and FACS sorting (ii). (D) Absence of G8600A mutation in patient's buccal epithelial cells.

Prelymphoid origin of G8600A mutation in B-CLL 33.

(A) G8600A mutation in DNA from tumor cells of patient with B-CLL 33 (i), separated to 99.8% purity using CD19 PE-coated magnetic beads (ii). (B) G8600A mutation together with a small peak of a normal sequence in DNA from CD3+ cells of patient with B-CLL 33 (i), separated to 95% purity using CD3 PE-coated magnetic beads (ii). (C) G8600A mutation in DNA from CD14+ cells of patient with B-CLL 33 (i) separated to 100% purity using CD14 labeling and FACS sorting (ii). (D) Absence of G8600A mutation in patient's buccal epithelial cells.

Close Modal

or Create an Account

Close Modal
Close Modal